ICUI
Get informed when a big investor buys or sells
+ FollowOvervalued by 15.6% based on the discounted cash flow analysis.
| Market cap | $4.01 Billion |
|---|---|
| Enterprise Value | $4.95 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.03 |
| Beta | 0.76 |
| Outstanding Shares | 25,000,000 |
| P/E Ratio | 133.6 |
|---|---|
| PEG | -290.51 |
| Price to Sales | 1.94 |
| Price to Book Ratio | 1.94 |
| Enterprise Value to Revenue | 2.29 |
| Enterprise Value to EBIT | 66.29 |
| Enterprise Value to Net Income | 129 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.58 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 22.16% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.33%▼ 104.20% |
|---|---|
| Total Invested | $53.20M▼ 98.62% |
| Investors Holding | 10▼ 283.00% |
No data
ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...